{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T23:23:40Z","timestamp":1773098620260,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"am","delay-in-days":373,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.bulcan.2021.05.007","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:23:47Z","timestamp":1632183827000},"page":"999-1009","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Chirurgie de r\u00e9duction de risque mammaire et d\u00e9couverte fortuite de cancer\u00a0: dix ans d\u2019exp\u00e9rience dans un centre de lutte contre le cancer"],"prefix":"10.1016","volume":"108","author":[{"given":"Manon","family":"Mangiardi-Veltin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0397-9889","authenticated-orcid":false,"given":"Foucauld","family":"Chamming's","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Jaffre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lien","family":"Rousvoal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Tunon de Lara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Brouste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"S\u00e9n\u00e9chal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2021.05.007_bib0100","unstructured":"International Agency for Research on Cancer. Global Cancer Observatory 2018. http:\/\/globocan.iarc.fr\/Default.aspx. (accessed August 5, 2018)."},{"key":"10.1016\/j.bulcan.2021.05.007_bib0105","unstructured":"Institut National du Cancer. Recommandations et R\u00e9f\u00e9rentiels - Femmes porteuses d\u2019une mutation de BRCA1\u00a0ou BRCA2\/D\u00e9tection pr\u00e9coce du cancer du sein et des annexes et strat\u00e9gies de r\u00e9duction du risque\u00a0\u2013\u00a0Ref: RECOBRCASYNTH17 | Institut National Du Cancer 2017."},{"key":"10.1016\/j.bulcan.2021.05.007_bib0110","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1\u00a0and BRCA2\u00a0mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.bulcan.2021.05.007_bib0115","unstructured":"Institut National du Cancer. Chirurgie prophylactique des cancers avec pr\u00e9disposition g\u00e9n\u00e9tique 2009."},{"key":"10.1016\/j.bulcan.2021.05.007_bib0120","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.patbio.2006.02.002","article-title":"Lefranc J-P, et al. Identification et prise en charge des pr\u00e9dispositions h\u00e9r\u00e9ditaires aux cancers du sein et de l\u2019ovaire (mise \u00e0 jour 2004)","volume":"54","author":"Eisinger","year":"2006","journal-title":"Pathol Biol"},{"key":"10.1016\/j.bulcan.2021.05.007_bib0125","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.amjsurg.2016.06.010","article-title":"Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review","volume":"212","author":"Ludwig","year":"2016","journal-title":"Am J Surg"},{"key":"10.1016\/j.bulcan.2021.05.007_bib0130","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10549-019-05345-2","article-title":"Survival after bilateral risk-reducing mastectomy in healthy BRCA1\u00a0and BRCA2\u00a0mutation carriers","volume":"177","author":"Heemskerk-Gerritsen","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.bulcan.2021.05.007_bib0135","article-title":"Risk-reducing mastectomy for the prevention of primary breast cancer","volume":"4","author":"Carbine","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bulcan.2021.05.007_bib0140","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.breast.2016.05.012","article-title":"Decision making, psychological wellbeing and psychosocial outcomes for high risk women who choose to undergo bilateral prophylactic mastectomy\u00a0\u2013\u00a0A review of the literature","volume":"28","author":"Glassey","year":"2016","journal-title":"Breast Edinb Scotl"},{"key":"10.1016\/j.bulcan.2021.05.007_bib0145","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1245\/s10434-015-4660-7","article-title":"Contralateral prophylactic mastectomy: factors predictive of occult malignancy or high-risk lesion and the impact of MRI and genetic testing","volume":"23","author":"Erdahl","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.bulcan.2021.05.007_bib0150","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1245\/s10434-015-4896-2","article-title":"Occult histopathology and its predictors in contralateral and bilateral prophylactic mastectomies","volume":"23","author":"Mattos","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.bulcan.2021.05.007_bib0155","unstructured":"UNICANCER\u00a0\u2013\u00a0Carte des instituts et centres de lutte contre le cancer\u00a0: unicancer en France n.d. http:\/\/www.unicancer.fr\/le-reseau-des-centres-de-lutte-contre-le-cancer. (accessed May 12, 2018)."},{"key":"10.1016\/j.bulcan.2021.05.007_bib0160","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13058-015-0650-8","article-title":"Longer term effects of the Angelina Jolie effect: increased risk-reducing mastectomy rates in BRCA carriers and other high-risk women","volume":"17","author":"Evans","year":"2015","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.bulcan.2021.05.007_bib0165","doi-asserted-by":"crossref","first-page":"i6357","DOI":"10.1136\/bmj.i6357","article-title":"Do celebrity endorsements matter? Observational study of BRCA gene testing and mastectomy rates after Angelina Jolie's New York Times editorial","volume":"355","author":"Desai","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.bulcan.2021.05.007_bib0170","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10549-018-4824-9","article-title":"Risk-reducing mastectomy rates in the US: a closer examination of the Angelina Jolie effect","volume":"171","author":"Liede","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.bulcan.2021.05.007_bib0175","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/jncimonographs\/lgi039","article-title":"Complications following bilateral prophylactic mastectomy","author":"Barton","year":"2005","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.bulcan.2021.05.007_bib0180","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.surg.2020.06.030","article-title":"The relationship between contralateral prophylactic mastectomy and breast reconstruction, complications, breast-related procedures, and costs: a population-based study of health insurance data","volume":"168","author":"Schroeder","year":"2020","journal-title":"Surgery"},{"key":"10.1016\/j.bulcan.2021.05.007_bib0185","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/PRS.0000000000007237","article-title":"Complications of contralateral prophylactic mastectomy: do they delay adjuvant therapy?","volume":"146","author":"Sharabi","year":"2020","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.bulcan.2021.05.007_bib0095","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.breast.2015.02.033","article-title":"Occult cancer in specimens of reduction mammaplasty aimed at symmetrization. A multicentric study of 2718\u00a0patients","volume":"24","author":"Sorin","year":"2015","journal-title":"Breast Edinb Scotl"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455121002988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455121002988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:34:38Z","timestamp":1757792078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455121002988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0007455121002988"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2021.05.007","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chirurgie de r\u00e9duction de risque mammaire et d\u00e9couverte fortuite de cancer\u00a0: dix ans d\u2019exp\u00e9rience dans un centre de lutte contre le cancer","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2021.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}